Harald Jorn Schneider

Summary

Affiliation: University of Munich
Country: Germany

Publications

  1. doi request reprint Prevalence of low male testosterone levels in primary care in Germany: cross-sectional results from the DETECT study
    Harald Jorn Schneider
    Medizinische Klinik, Ludwig Maximilian University, Innenstadt, Munich, Germany
    Clin Endocrinol (Oxf) 70:446-54. 2009
  2. pmc Incremental effects of endocrine and metabolic biomarkers and abdominal obesity on cardiovascular mortality prediction
    Harald Jorn Schneider
    Institute of Clinical Chemistry and Laboratory Medicine, Ernst Moritz Arndt University Greifswald, Greifswald, Germany
    PLoS ONE 7:e33084. 2012
  3. doi request reprint The predictive value of different measures of obesity for incident cardiovascular events and mortality
    Harald J Schneider
    Medizinische Klinik Innenstadt, Ludwig Maximilians University, Ziemssenstrasse 1, 80336 Munich, Germany
    J Clin Endocrinol Metab 95:1777-85. 2010
  4. doi request reprint Prediction of incident diabetes mellitus by baseline IGF1 levels
    Harald Jorn Schneider
    Medizinische Klinik Innenstadt, Ludwig Maximilians University, Munich, Germany
    Eur J Endocrinol 164:223-9. 2011
  5. doi request reprint Effects of growth hormone replacement within the KIMS survey on estimated cardiovascular risk and predictors of risk reduction in patients with growth hormone deficiency
    Harald Jorn Schneider
    Medizinische Klinik Innenstadt, Ludwig Maximilians University, Munich, Germany
    Clin Endocrinol (Oxf) 75:825-30. 2011
  6. doi request reprint Structured assessment of hypopituitarism after traumatic brain injury and aneurysmal subarachnoid hemorrhage in 1242 patients: the German interdisciplinary database
    Harald J Schneider
    Medizinische Klinik Innenstadt, Ludwig Maximilians University, Munich, Germany
    J Neurotrauma 28:1693-8. 2011
  7. doi request reprint High prevalence of biochemical acromegaly in primary care patients with elevated IGF-1 levels
    H J Schneider
    Medizinische Klinik Innenstadt, Ludwig Maximilian University, Munich, Germany
    Clin Endocrinol (Oxf) 69:432-5. 2008
  8. doi request reprint A novel approach to the detection of acromegaly: accuracy of diagnosis by automatic face classification
    Harald J Schneider
    Medizinische Klinik, Innenstadt, Ludwig Maximilians University, Ziemssenstrasse 1, 80336 Munich, Germany
    J Clin Endocrinol Metab 96:2074-80. 2011
  9. ncbi request reprint Hypothalamopituitary dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a systematic review
    Harald Jorn Schneider
    Neuroendocrinology Group, Max Planck Institute of Psychiatry, Munich, Germany
    JAMA 298:1429-38. 2007
  10. doi request reprint Prevalence of mental disorders in acromegaly: a cross-sectional study in 81 acromegalic patients
    Caroline Sievers
    Departments of Endocrinology and Molecular Psychology, Max Planck Institute of Psychiatry, Kraepelinstrasse 2 10, Munich, Germany
    Clin Endocrinol (Oxf) 71:691-701. 2009

Detail Information

Publications14

  1. doi request reprint Prevalence of low male testosterone levels in primary care in Germany: cross-sectional results from the DETECT study
    Harald Jorn Schneider
    Medizinische Klinik, Ludwig Maximilian University, Innenstadt, Munich, Germany
    Clin Endocrinol (Oxf) 70:446-54. 2009
    ....
  2. pmc Incremental effects of endocrine and metabolic biomarkers and abdominal obesity on cardiovascular mortality prediction
    Harald Jorn Schneider
    Institute of Clinical Chemistry and Laboratory Medicine, Ernst Moritz Arndt University Greifswald, Greifswald, Germany
    PLoS ONE 7:e33084. 2012
    ..We aimed to determine if the addition of endocrine, metabolic, and obesity-associated biomarkers to conventional risk factors improves the prediction of cardiovascular and all-cause mortality...
  3. doi request reprint The predictive value of different measures of obesity for incident cardiovascular events and mortality
    Harald J Schneider
    Medizinische Klinik Innenstadt, Ludwig Maximilians University, Ziemssenstrasse 1, 80336 Munich, Germany
    J Clin Endocrinol Metab 95:1777-85. 2010
    ..To date, it is unclear which measure of obesity is the most appropriate for risk stratification...
  4. doi request reprint Prediction of incident diabetes mellitus by baseline IGF1 levels
    Harald Jorn Schneider
    Medizinische Klinik Innenstadt, Ludwig Maximilians University, Munich, Germany
    Eur J Endocrinol 164:223-9. 2011
    ..We hypothesized that both low- and high-IGF1 levels increase the risk of diabetes and aimed to assess the role of IGF1 in the risk of developing diabetes in a large prospective study...
  5. doi request reprint Effects of growth hormone replacement within the KIMS survey on estimated cardiovascular risk and predictors of risk reduction in patients with growth hormone deficiency
    Harald Jorn Schneider
    Medizinische Klinik Innenstadt, Ludwig Maximilians University, Munich, Germany
    Clin Endocrinol (Oxf) 75:825-30. 2011
    ..We aimed at estimating CV risk with established algorithms before and during GH replacement in GHD and in healthy controls and at identifying predictors of risk reduction...
  6. doi request reprint Structured assessment of hypopituitarism after traumatic brain injury and aneurysmal subarachnoid hemorrhage in 1242 patients: the German interdisciplinary database
    Harald J Schneider
    Medizinische Klinik Innenstadt, Ludwig Maximilians University, Munich, Germany
    J Neurotrauma 28:1693-8. 2011
    ..In conclusion, our data confirm that hypopituitarism is a common complication of TBI and SAH. It is possible that patients with a higher likelihood of hypopituitarism were selected for endocrine stimulation tests...
  7. doi request reprint High prevalence of biochemical acromegaly in primary care patients with elevated IGF-1 levels
    H J Schneider
    Medizinische Klinik Innenstadt, Ludwig Maximilian University, Munich, Germany
    Clin Endocrinol (Oxf) 69:432-5. 2008
    ..It is not known how many subjects with increased IGF-1 levels have acromegaly. We aimed to assess the prevalence of acromegaly in primary care by screening for elevated IGF-1 levels...
  8. doi request reprint A novel approach to the detection of acromegaly: accuracy of diagnosis by automatic face classification
    Harald J Schneider
    Medizinische Klinik, Innenstadt, Ludwig Maximilians University, Ziemssenstrasse 1, 80336 Munich, Germany
    J Clin Endocrinol Metab 96:2074-80. 2011
    ..The delay between onset of first symptoms and diagnosis of the acromegaly is 6-10 yr. Acromegaly causes typical changes of the face that might be recognized by face classification software...
  9. ncbi request reprint Hypothalamopituitary dysfunction following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a systematic review
    Harald Jorn Schneider
    Neuroendocrinology Group, Max Planck Institute of Psychiatry, Munich, Germany
    JAMA 298:1429-38. 2007
    ..This sequela is a potentially serious but treatable complication of brain injury...
  10. doi request reprint Prevalence of mental disorders in acromegaly: a cross-sectional study in 81 acromegalic patients
    Caroline Sievers
    Departments of Endocrinology and Molecular Psychology, Max Planck Institute of Psychiatry, Kraepelinstrasse 2 10, Munich, Germany
    Clin Endocrinol (Oxf) 71:691-701. 2009
    ....
  11. ncbi request reprint Anterior pituitary hormone abnormalities following traumatic brain injury
    Manfred Schneider
    Internal Medicine Endocrinology and Clinical Chemistry, Max Planck Institute of Psychiatry, Munich, Germany
    J Neurotrauma 22:937-46. 2005
    ..This review updates clinical researchers, physicians, and other healthcare providers on the relationship between TBI and subsequent anterior pituitary insufficiency...
  12. ncbi request reprint Enantio-selective effects of clenbuterol in cultured neurons and astrocytes, and in a mouse model of cerebral ischemia
    Carsten Culmsee
    Institut fur Pharmakologie und Toxikologie, Philipps Universitat Marburg, Germany
    Eur J Pharmacol 575:57-65. 2007
    ..These results clearly demonstrate that S(+)-clenbuterol is the eutomer that mediates neuroprotective effects of the beta(2)-adrenoceptor agonist but also according changes of physiological parameters...
  13. doi request reprint Screening for hypopituitarism in 509 patients with traumatic brain injury or subarachnoid hemorrhage
    Anna Kopczak
    1 Clinical Neuroendocrinology, Max Planck Institute of Psychiatry, Munich, Germany
    J Neurotrauma 31:99-107. 2014
    ..A routine screening of all patients in neurorehabilitation without considering the time since injury, the severity of illness and therapeutic consequences seems not useful. ..
  14. doi request reprint Efficacy of a polyethylene glycol marker system in urine drug screening in an opiate substitution program
    Harald Jorn Schneider
    Department of Addiction Medicine, Hospital München Schwabing, Munich, Germany
    Eur Addict Res 14:186-9. 2008
    ..A recently developed polyethylene glycol marker system allows reliable identification of urine samples. In this study, we aimed to compare the rates of drug detection in conventional and marker urine samples...